KALA BIO, Inc. (KALA)

CIK 1479419 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for KALA BIO, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 2026PRE 14A0001829126-26-010053
Sep 10, 20268-K0001829126-26-009999
Sep 9, 20268-K0001829126-26-009946
Aug 28, 20268-K0001829126-26-009454
Aug 19, 202610-Q0001104659-26-098783
Aug 14, 2026NT 10-Q0001829126-26-008832
Jul 23, 20268-K0001829126-26-007760
Jul 22, 2026424B50001829126-26-007754
Jul 2, 2026SCHEDULE 13D/A0001829126-26-007224
Jun 25, 2026EFFECT9999999995-26-002122
Jun 12, 2026S-3/A0001829126-26-006442
May 15, 2026SCHEDULE 13G/A0001104659-26-062584
May 15, 202610-Q0001104659-26-062397
May 7, 2026S-30001829126-26-004790
May 7, 20268-K0001829126-26-004744
Apr 15, 202610-K0001104659-26-043782
Mar 31, 2026NT 10-K0001829126-26-002931
Mar 17, 20261440001950047-26-002718
Mar 17, 2026D0001829126-26-002408
Mar 12, 20261440001950047-26-002562
Mar 12, 20261440001950047-26-002513
Mar 4, 20268-K0001829126-26-001911
Feb 20, 20268-K0001829126-26-001534
Feb 17, 2026424B30001829126-26-001400
Feb 17, 2026EFFECT9999999995-26-000615